Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Pharma
Lilly, J&J launches top Clarivate's Drugs to Watch 2026 report
Two investigational cardiometabolic drugs from Eli Lilly stand out in Clarivate's annual Drugs to Watch report. J&J also has two drugs on the list.
Kevin Dunleavy
Jan 7, 2026 9:28am
The stories that captivated our audience in 2025
Dec 23, 2025 10:15am
Cytokinetics scores its first FDA nod with Myqorzo approval
Dec 22, 2025 12:05pm
9 pharmas reach US drug price deals with Trump administration
Dec 19, 2025 3:35pm
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree
Dec 19, 2025 10:44am
Enhertu, ADC trial deaths, Takeda—Fierce Pharma Asia
Dec 19, 2025 8:00am
